Figure 5 | Scientific Reports

Figure 5

From: Cutaneous adverse events in patients treated with PD-1/PD-L1 checkpoint inhibitors and their association with survival: a systematic review and meta-analysis

Figure 5

Forest plot showing the association between irCAE occurrence and OS, publication bias analysis, and sensitivity analysis. (a) Subgroup analysis among cancer types and OS. (b) Funnel plot of the OS. (c) Sensitivity analysis of the OS. IrCAEs, immune-related cutaneous adverse events; OS, overall survival; Freeman-Keller-1, OS data for rash; Freeman-Keller-2, OS data for vitiligo.

Back to article page